Amicus Therapeutics to Present at Upcoming Investor Conferences

PHILADELPHIA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences:

• SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 12:00 p.m. E.T.
• Cowen 41st Annual Health Care Conference on Wednesday, March 3, 2021 at 12:20 p.m. E.T.

A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.

About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company’s website at www.amicusrx.com, and follow us on Twitter and LinkedIn.

CONTACT:

Investors:Andrew FaughnanSr. Director, Investor Relations[email protected](609) 662-3809

Media:Diana MooreHead of Global Corporate Communications[email protected](609) 662-5079

FOLD–G

Source: Amicus Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Green Thumb Opens Its 24th Florida Location, RISE Dispensary Port St. Lucie, on August 22
• Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
• Best AI Meme Coin Presale 2026: MemeToro Combines AI Agents With BNB Chain Infrastructure